The evolving role of drug metabolism in drug discovery and development.
about
Advances in computationally modeling human oral bioavailabilityA chiral liquid chromatography method for the simultaneous determination of oxcarbazepine, eslicarbazepine, R-licarbazepine and other new chemical derivatives BIA 2-024, BIA 2-059 and BIA 2-265, in mouse plasma and brain.Liquid chromatography/quadrupole time-of-flight mass spectrometry in combination with online hydrogen/deuterium exchange technique for structural elucidation of phase I metabolites of iso-phenylcyclopentylamine in rat bile.Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion in the study of anemoside B4, a novel antiviral agent candidate, in rats.The effect of oral lipids and circulating lipoproteins on the metabolism of drugs.Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.Preclinical in vivo ADME studies in drug development: a critical review.Comparative metabolism as a key driver of wildlife species sensitivity to human and veterinary pharmaceuticals.Modeling bioavailability to organs protected by biological barriers.Interspecies Variation of In Vitro Stability and Metabolic Diversity of YZG-331, a Promising Sedative-Hypnotic Compound.Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.The use of isolated enterocytes to study Phase I intestinal drug metabolism: validation with rat and pig intestine.Metabolism elucidation of BJ-B11 (a heat shock protein 90 inhibitor) by human liver microsomes: identification of main contributing enzymes.
P2860
Q27008316-4AA8F5F4-1C3D-41F7-AAB8-CE71FF4F40DBQ33968508-03064F6D-2D3C-4424-853D-08B37295FF2DQ35123312-E033FA6A-8AA7-415D-92BB-3CD6212C5C07Q36221394-0F6672D6-DE6A-49D0-B118-264B332DC7B6Q37575518-AB4CB743-DA20-443B-9171-16ED6F591BB9Q37740151-25467346-202A-468C-B767-3FD85E308D7EQ37976124-DDBB4B22-B40F-447E-8491-A961E8E1AC25Q38269162-CDE47459-1776-483A-8063-4050938E21D0Q38288015-A507613F-D96B-4BF0-9B7A-70DB3380C8ECQ38604902-B04FDD3E-CFA1-4C45-9813-83FF3229498AQ39773779-33EBDDF5-7850-48D3-A07F-3A46550BD03DQ48308026-501C06EA-6A93-49F6-9CBE-8F391D659AD9Q53467993-E87B4B6B-548C-4E02-AE82-7408F3A8F1E1
P2860
The evolving role of drug metabolism in drug discovery and development.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The evolving role of drug metabolism in drug discovery and development.
@en
type
label
The evolving role of drug metabolism in drug discovery and development.
@en
prefLabel
The evolving role of drug metabolism in drug discovery and development.
@en
P2093
P1476
The evolving role of drug metabolism in drug discovery and development.
@en
P2093
Lilian G Yengi
Louis Leung
P304
P356
10.1007/S11095-006-9217-9
P577
2007-03-01T00:00:00Z